Juerg Schwitter
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Juerg Schwitter has a total of 600 co-authors. Here are the top co-authors by number of shared publications:
- Pierre Monney
Department of Cardiology, Lausanne University Hospital and University of Lausanne , Lausanne
17 shared publications - Anna Giulia Pavon
Department of Medical and Surgical Sciences (DIMEC), Alma Mater Studiorum – University of Bologna , via Massarenti 9, Bologna 40138
16 shared publications - Pier Giorgio Masci
Department of Cardiovascular Imaging, School of Biomedical Engineering and Imaging Sciences, King’s College London, United Kingdom (O.M., P.G.M.).
11 shared publications - Tobias Rutz
Service of Cardiology, Lausanne University Hospital and University of Lausanne , Rue du Bugnon 46, 1011 Lausanne
11 shared publications Ambra Masi
10 shared publications- Matthias Stuber
IHU LIRYC, Heart Rhythm Disease Institute, Hôpital Xavier Arnozan, Université de Bordeaux—INSERM U1045 , Avenue du Haut Lévêque, Pessac 33604
9 shared publications
Latest Publications
- Open Access
- 24 June 2026
- Published by Wiley in Journal of Magnetic Resonance Imaging
- Vol. 64 (4) , 996-1008
Performance of Free‐Running Cardiac and Respiratory Motion‐Resolved Whole‐Heart 5D MRI in Congenital Heart Disease Patients Using a Gadolinium Enhanced Fast‐Interrupted Steady‐State Sequence
Background: The performance of 5D imaging in CHD has been previously demonstrated using ferumoxytol rather than gadolinium. Purpose: To evaluate the performance of gadolinium enhanced 5D MRI relative to 2D and 3D MRI in CHD patients. Study Type: Retrospective. Subjects: 45 consecutive CHD patients referred for clinically indicated MRI who underwent 2D, 3D, and 5D MRI. Field Strength/Sequence: 2D bSSFP CINE, 3D bSSFP, and 5D FISS at 1.5 T. Assessment: Scan time (2D, 3D, and 5D), left and right ventricular (LV, RV) end diastolic and end systolic volumes (LVEDV, RVEDV, LVESV, and RVESV, respectively), ejection fraction (LVEF, RVEF) for 2D versus 5D, and image quality on a 4‐point Likert scale (3D vs. 5D). Statistical Tests: Paired comparisons were made using a paired t ‐test or Wilcoxon signed rank test. Agreement between measurements was evaluated with Bland–Altman analysis including the bias and 95% limits of agreement. Results: Scan time for 5D (6:18 [0]) was significantly shorter than 2D (7:16 [4:39]) and 3D (6:55 [1:30]) MRI. 5D measurements were strongly correlated with 2D measurements of LVEDV ( R 2 = 0.94), LVESV ( R 2 = 0.83), LVEF ( R 2 = 0.51), ( R 2 = 0.85), RVESV ( R 2 = 0.80), and RVEF ( R 2 = 0.66) but with significant biases. Sharpness of the coronary arteries were significantly higher for 3D (RCA: 36.8% ± 10.2%, LAD: 40.5% ± 10.5%) than 5D (RCA: 24.3% ± 7.5%, LAD: 31.7% ± 8.7%), but longer vessel segments were visible using 5D (LAD: 6.9 ± 2.5) than 3D (LAD: 5.3 ± 2.9 mm) acquisitions. The grades for 5D (R1: 3 [1], R2: 2.5 [0.5], R3: 3 [0.6]) were significantly higher than 3D (R1: 3 [1], R2: 2.5 [1], R3: 2 [1]). Data Conclusion: Gadolinium‐enhanced 5D MRI may provide an efficient and simplified acquisition for CHD patients, with multiple quantitative parameters from 5D being not significantly different from those from reference standard 2D and 3D MRI. Evidence Level: 4 Stage of Technical Efficacy: 1
- 24 June 2026
- Published by Wiley in Journal of Magnetic Resonance Imaging
- Vol. 64 (4) , 996-1008
Open AccessPerformance of Free‐Running Cardiac and Respiratory Motion‐Resolved Whole‐Heart 5D MRI in Congenital Heart Disease Patients Using a Gadolinium Enhanced Fast‐Interrupted Steady‐State Sequence
Background: The performance of 5D imaging in CHD has been previously demonstrated using ferumoxytol rather than gadolinium. Purpose: To evaluate the performance of gadolinium enhanced 5D MRI relative to 2D and 3D MRI in CHD patients. Study Type: Retrospective. Subjects: 45 consecutive CHD patients referred for clinically indicated MRI who underwent 2D, 3D, and 5D MRI. Field Strength/Sequence: 2D bSSFP CINE, 3D bSSFP, and 5D FISS at 1.5 T. Assessment: Scan time (2D, 3D, and 5D), left and right ventricular (LV, RV) end diastolic and end systolic volumes (LVEDV, RVEDV, LVESV, and RVESV, respectively), ejection fraction (LVEF, RVEF) for 2D versus 5D, and image quality on a 4‐point Likert scale (3D vs. 5D). Statistical Tests: Paired comparisons were made using a paired t ‐test or Wilcoxon signed rank test. Agreement between measurements was evaluated with Bland–Altman analysis including the bias and 95% limits of agreement. Results: Scan time for 5D (6:18 [0]) was significantly shorter than 2D (7:16 [4:39]) and 3D (6:55 [1:30]) MRI. 5D measurements were strongly correlated with 2D measurements of LVEDV ( R 2 = 0.94), LVESV ( R 2 = 0.83), LVEF ( R 2 = 0.51), ( R 2 = 0.85), RVESV ( R 2 = 0.80), and RVEF ( R 2 = 0.66) but with significant biases. Sharpness of the coronary arteries were significantly higher for 3D (RCA: 36.8% ± 10.2%, LAD: 40.5% ± 10.5%) than 5D (RCA: 24.3% ± 7.5%, LAD: 31.7% ± 8.7%), but longer vessel segments were visible using 5D (LAD: 6.9 ± 2.5) than 3D (LAD: 5.3 ± 2.9 mm) acquisitions. The grades for 5D (R1: 3 [1], R2: 2.5 [0.5], R3: 3 [0.6]) were significantly higher than 3D (R1: 3 [1], R2: 2.5 [1], R3: 2 [1]). Data Conclusion: Gadolinium‐enhanced 5D MRI may provide an efficient and simplified acquisition for CHD patients, with multiple quantitative parameters from 5D being not significantly different from those from reference standard 2D and 3D MRI. Evidence Level: 4 Stage of Technical Efficacy: 1
- 20 May 2026
- Published by Elsevier in JACC: Cardiovascular Imaging
- Vol. 19 (10) , 1256-1270
Multiparametric Cardiac Magnetic Resonance Characterization of the Noninfarcted Myocardium
- 20 May 2026
- Published by Elsevier in JACC: Cardiovascular Imaging
- Vol. 19 (10) , 1256-1270
Multiparametric Cardiac Magnetic Resonance Characterization of the Noninfarcted Myocardium
- Open Access
- 5 May 2026
- Published by Oxford University Press (OUP) in ESC Heart Failure
- Vol. 13 (3)
Cardiac magnetic resonance-derived left atrioventricular coupling index predicts outcome in reduced ejection fraction
Introduction: The left atrioventricular coupling index (LACI) has emerged as a potential prognostic marker in several clinical settings. This study evaluated the prognostic value of cardiac magnetic resonance (CMR)-derived LACI in patients with heart failure (HF) and reduced left ventricular ejection fraction (LVEF). Methods: Patients from the multicentre DERIVATE registry with LVEF <50% who underwent CMR were included. LACI was calculated as the ratio between left atrial and left ventricular end-diastolic volumes. Univariable and multivariable Cox regression models estimated hazard ratios (HR) with 95% confidence intervals (CI) for predicting all-cause mortality (ACM), ACM or HF, and HF alone (competing-risk analysis). Time-dependent receiver operating characteristic analysis identified optimal cut-offs for 3-year outcomes. Results: A total of 2170 patients were included (mean age 59.8 ± 13.9 years; 24.7% women; mean LVEF 31.6 ± 11.3%). Median follow-up was 1016 days (580–1609). Median LACI was 19.4% (13.3–28.8). During follow-up, ACM occurred in 191 patients (8.8%), ACM or HF in 565 (26.0%), and HF in 442 (20.4%). After adjustment for clinical and CMR parameters, including LVEF and late gadolinium enhancement (LGE), each 5% increase in LACI was associated with higher risk of ACM (HR 1.06, 95% CI 1.01–1.11; P = .016), ACM or HF (HR 1.09, 95% CI 1.06–1.12; P < .001), and HF (HR 1.09, 95% CI 1.05–1.12; P < .001). The optimal cut-off for ACM was LACI ≥21% (AUC 0.617, 95% CI 0.561–0.673), identifying patients at higher risk of ACM, ACM or HF, and HF (log-rank P < .001 for all). Conclusion: CMR-derived LACI independently predicts ACM and HF in patients with reduced LVEF and provides incremental prognostic value beyond LVEF and LGE. A cut-off of ≥21% identifies higher-risk patients and may support clinical risk stratification.
- 5 May 2026
- Published by Oxford University Press (OUP) in ESC Heart Failure
- Vol. 13 (3)
Open AccessCardiac magnetic resonance-derived left atrioventricular coupling index predicts outcome in reduced ejection fraction
Introduction: The left atrioventricular coupling index (LACI) has emerged as a potential prognostic marker in several clinical settings. This study evaluated the prognostic value of cardiac magnetic resonance (CMR)-derived LACI in patients with heart failure (HF) and reduced left ventricular ejection fraction (LVEF). Methods: Patients from the multicentre DERIVATE registry with LVEF <50% who underwent CMR were included. LACI was calculated as the ratio between left atrial and left ventricular end-diastolic volumes. Univariable and multivariable Cox regression models estimated hazard ratios (HR) with 95% confidence intervals (CI) for predicting all-cause mortality (ACM), ACM or HF, and HF alone (competing-risk analysis). Time-dependent receiver operating characteristic analysis identified optimal cut-offs for 3-year outcomes. Results: A total of 2170 patients were included (mean age 59.8 ± 13.9 years; 24.7% women; mean LVEF 31.6 ± 11.3%). Median follow-up was 1016 days (580–1609). Median LACI was 19.4% (13.3–28.8). During follow-up, ACM occurred in 191 patients (8.8%), ACM or HF in 565 (26.0%), and HF in 442 (20.4%). After adjustment for clinical and CMR parameters, including LVEF and late gadolinium enhancement (LGE), each 5% increase in LACI was associated with higher risk of ACM (HR 1.06, 95% CI 1.01–1.11; P = .016), ACM or HF (HR 1.09, 95% CI 1.06–1.12; P < .001), and HF (HR 1.09, 95% CI 1.05–1.12; P < .001). The optimal cut-off for ACM was LACI ≥21% (AUC 0.617, 95% CI 0.561–0.673), identifying patients at higher risk of ACM, ACM or HF, and HF (log-rank P < .001 for all). Conclusion: CMR-derived LACI independently predicts ACM and HF in patients with reduced LVEF and provides incremental prognostic value beyond LVEF and LGE. A cut-off of ≥21% identifies higher-risk patients and may support clinical risk stratification.
- Open Access
- 25 March 2026
- Published by Elsevier in Heart Rhythm O2
- Vol. 7 (7) , 1314-1323
Training in a novel advanced augmented reality-based ablation simulator: Using 3-dimensional magnetic resonance heart models of individual patients improves performance of future electrophysiologists
- 25 March 2026
- Published by Elsevier in Heart Rhythm O2
- Vol. 7 (7) , 1314-1323
Open AccessTraining in a novel advanced augmented reality-based ablation simulator: Using 3-dimensional magnetic resonance heart models of individual patients improves performance of future electrophysiologists
- Open Access
- 1 January 2026
- Published by Oxford University Press (OUP) in European Heart Journal - Imaging Methods and Practice
- Vol. 4 (1) , qyag102
Wideband black- and bright-blood late gadolinium enhancement imaging in patients with implantable cardiac devices at 1.5 T for improved visualization and localization of myocardial injury
Aims: Late gadolinium enhancement (LGE) imaging in patients with implantable cardiac devices is often degraded by device-related artefacts. Wideband phase-sensitive inversion recovery (PSIR) mitigates these artefacts but suffers from low scar-blood contrast, limiting detection of subendocardial and small focal scars. Therefore, a novel wideband SPOT (Scar-specific imaging with Preserved myOcardial visualizaTion) sequence combining co-registered wideband black- and bright-blood LGE to improve scar-blood contrast and localization, with wideband inversion recovery and wideband T2 preparation for artefact reduction, was implemented at 1.5 T. Methods and results: Wideband SPOT was compared with wideband PSIR, conventional PSIR, and conventional SPOT in an animal and 18 patients with devices and known myocardial lesions. Patient analyses included qualitative assessment of image quality, artefact severity, diagnostic confidence, and LGE segment detection; quantitative measurements of left ventricular (LV) volume, scar volume, and scar size; agreement analysis between wideband SPOT and wideband PSIR; and reproducibility analysis. In the animal, wideband SPOT reduced device-related artefacts and enabled accurate scar localization consistent with histology. In patients, wideband SPOT and wideband PSIR yielded similar image and artefact reduction (P > 0.05), but wideband SPOT reduced diagnostic uncertainty by 24% (P = 0.080). Inter-observer agreement for qualitative scores was moderate to good [intra-class correlation coefficient (ICC) 0.54–0.83, P < 0.001]. Quantitative LV and scar measurements demonstrated excellent correlation (r > 0.9, P < 0.01) and good-to-excellent reproducibility (ICC 0.85–0.98, P < 0.001) between techniques. Conclusion: Compared with wideband PSIR, wideband SPOT showed a trend towards enhanced scar detection, identifying additional scarred segments while maintaining similar overall scar burden. It also improved inter-observer agreement, preserved anatomical reference, and reduced device artefacts, which may improve diagnostic confidence and risk stratification.
- 1 January 2026
- Published by Oxford University Press (OUP) in European Heart Journal - Imaging Methods and Practice
- Vol. 4 (1) , qyag102
Open AccessWideband black- and bright-blood late gadolinium enhancement imaging in patients with implantable cardiac devices at 1.5 T for improved visualization and localization of myocardial injury
Aims: Late gadolinium enhancement (LGE) imaging in patients with implantable cardiac devices is often degraded by device-related artefacts. Wideband phase-sensitive inversion recovery (PSIR) mitigates these artefacts but suffers from low scar-blood contrast, limiting detection of subendocardial and small focal scars. Therefore, a novel wideband SPOT (Scar-specific imaging with Preserved myOcardial visualizaTion) sequence combining co-registered wideband black- and bright-blood LGE to improve scar-blood contrast and localization, with wideband inversion recovery and wideband T2 preparation for artefact reduction, was implemented at 1.5 T. Methods and results: Wideband SPOT was compared with wideband PSIR, conventional PSIR, and conventional SPOT in an animal and 18 patients with devices and known myocardial lesions. Patient analyses included qualitative assessment of image quality, artefact severity, diagnostic confidence, and LGE segment detection; quantitative measurements of left ventricular (LV) volume, scar volume, and scar size; agreement analysis between wideband SPOT and wideband PSIR; and reproducibility analysis. In the animal, wideband SPOT reduced device-related artefacts and enabled accurate scar localization consistent with histology. In patients, wideband SPOT and wideband PSIR yielded similar image and artefact reduction (P > 0.05), but wideband SPOT reduced diagnostic uncertainty by 24% (P = 0.080). Inter-observer agreement for qualitative scores was moderate to good [intra-class correlation coefficient (ICC) 0.54–0.83, P < 0.001]. Quantitative LV and scar measurements demonstrated excellent correlation (r > 0.9, P < 0.01) and good-to-excellent reproducibility (ICC 0.85–0.98, P < 0.001) between techniques. Conclusion: Compared with wideband PSIR, wideband SPOT showed a trend towards enhanced scar detection, identifying additional scarred segments while maintaining similar overall scar burden. It also improved inter-observer agreement, preserved anatomical reference, and reduced device artefacts, which may improve diagnostic confidence and risk stratification.
- Open Access
- 6 October 2025
- Published by Oxford University Press (OUP) in European Heart Journal - Imaging Methods and Practice
- Vol. 3 (4)
Correlation of cavotricuspid isthmus dynamics with clinical parameters: insights from interventional cardiac magnetic resonance imaging
Aims: Ablation of typical atrial flutter (AFL) within an interventional cardiac magnetic resonance (iCMR) is a novel treatment modality. This study aims to describe the segmental kinetics of the cavotricuspid isthmus (CTI) during iCMR-guided ablation for AFL, to evaluate the impact of CTI dynamics on procedural time, to assess the utility of machine learning (ML) for clustering patient profiles based on CTI kinetics, and to identify clinical factors influencing CTI kinetics. Methods and results: A cohort of 32 patients underwent first-time iCMR-guided CTI ablation while in sinus rhythm, of whom 15 (47%) underwent a successful electrical cardioversion (EC) within 12 h before the procedure. CTI delineation and measurements were retrospectively performed using TOMTEC-ARENA™ software. Normalized elongation (NE) was defined as the ratio between CTI elongation and CTI length during right atrial systole. Unsupervised ML (K-means clustering) was used for patients’ classification. Segmental analysis revealed greater displacements for CTI segments near the tricuspid valve compared with those near the Eustachian valve. K-means clustering identified three patient groups: low, intermediate, and high NE. Prior EC was significantly associated with low NE (P < 0.05), suggesting myocardial stunning. Hypokinetic CTIs were more prevalent among patients with dyslipidaemia, smoking history, and elevated BMI. Conclusion: This study provides the first detailed description of segmental CTI dynamics during iCMR-guided AFL ablation. NE emerged as a valuable metric for characterizing CTI kinetics. A clinical profile including a history of EC, smoking status, elevated BMI, and dyslipidaemia, was linked to reduced CTI kinetics suggestive of right atrial cardiomyopathy.
- 6 October 2025
- Published by Oxford University Press (OUP) in European Heart Journal - Imaging Methods and Practice
- Vol. 3 (4)
Open AccessCorrelation of cavotricuspid isthmus dynamics with clinical parameters: insights from interventional cardiac magnetic resonance imaging
Aims: Ablation of typical atrial flutter (AFL) within an interventional cardiac magnetic resonance (iCMR) is a novel treatment modality. This study aims to describe the segmental kinetics of the cavotricuspid isthmus (CTI) during iCMR-guided ablation for AFL, to evaluate the impact of CTI dynamics on procedural time, to assess the utility of machine learning (ML) for clustering patient profiles based on CTI kinetics, and to identify clinical factors influencing CTI kinetics. Methods and results: A cohort of 32 patients underwent first-time iCMR-guided CTI ablation while in sinus rhythm, of whom 15 (47%) underwent a successful electrical cardioversion (EC) within 12 h before the procedure. CTI delineation and measurements were retrospectively performed using TOMTEC-ARENA™ software. Normalized elongation (NE) was defined as the ratio between CTI elongation and CTI length during right atrial systole. Unsupervised ML (K-means clustering) was used for patients’ classification. Segmental analysis revealed greater displacements for CTI segments near the tricuspid valve compared with those near the Eustachian valve. K-means clustering identified three patient groups: low, intermediate, and high NE. Prior EC was significantly associated with low NE (P < 0.05), suggesting myocardial stunning. Hypokinetic CTIs were more prevalent among patients with dyslipidaemia, smoking history, and elevated BMI. Conclusion: This study provides the first detailed description of segmental CTI dynamics during iCMR-guided AFL ablation. NE emerged as a valuable metric for characterizing CTI kinetics. A clinical profile including a history of EC, smoking status, elevated BMI, and dyslipidaemia, was linked to reduced CTI kinetics suggestive of right atrial cardiomyopathy.
- 29 July 2025
- Published by Oxford University Press (OUP) in European Heart Journal - Cardiovascular Imaging
Redefining the risk of major arrhythmic events in non-ischaemic cardiomyopathy: insights from the DERIVATE-NICM study
Aims: Selection of the patients for implantable cardioverter defibrillator primary prevention therapy in non-ischaemic cardiomyopathy (NICM) needs to be improved. To evaluate the additional prognostic value of a new cardiac magnetic resonance (CMR) score based on late gadolinium enhancement (LGE) pattern distribution (DERIVATE Risk Score 2.0) when compared with previously published DERIVATE Risk Score 1.0, which is based solely on quantitative parameters, in a cohort of NICM patients enrolled in the DERIVATE registry. Methods and results: One thousand three hundred and eighty-four NICM patients with chronic heart failure and left ventricular ejection fraction (LVEF) < 50% were evaluated for primary sudden cardiac death prevention therapy. Major adverse arrhythmic cardiac events (MAACEs) were the primary endpoint. During a median follow-up of 959 days, MAACE occurred in 128 (9.2%) patients. In the multivariate analyses, male gender [hazard ratio (HR): 1.605 (95% confidence interval, CI: 1.051–2.451); P = 0.028], LVEF per point % [HR: 0.977 (95% CI: 0.961–0.993); P = 0.005] and presence and location of midwall LGE [weighted HR: 1.066 (95% CI: 1.045–1.086), P < 0.001] were independent predictors of MAACE. A multi-parametric CMR-weighted predictive-derived score (DERIVATE Risk Score 2.0) provided a higher additional prognostic value vs. transthoracic echocardiography–LVEF cut-off of 35% when compared with the previous published DERIVATE Risk Score 1.0 with a net reclassification improvement of 54.52% (95% CI: 36.52–72.52%; P < 0.001). These findings were confirmed in the validation cohort. Conclusion: The presence of midwall LGE, but also the location of scar, confers an added and independent MAACE risk to a large NICM population influencing the choice of treatment.
- 29 July 2025
- Published by Oxford University Press (OUP) in European Heart Journal - Cardiovascular Imaging
Redefining the risk of major arrhythmic events in non-ischaemic cardiomyopathy: insights from the DERIVATE-NICM study
Aims: Selection of the patients for implantable cardioverter defibrillator primary prevention therapy in non-ischaemic cardiomyopathy (NICM) needs to be improved. To evaluate the additional prognostic value of a new cardiac magnetic resonance (CMR) score based on late gadolinium enhancement (LGE) pattern distribution (DERIVATE Risk Score 2.0) when compared with previously published DERIVATE Risk Score 1.0, which is based solely on quantitative parameters, in a cohort of NICM patients enrolled in the DERIVATE registry. Methods and results: One thousand three hundred and eighty-four NICM patients with chronic heart failure and left ventricular ejection fraction (LVEF) < 50% were evaluated for primary sudden cardiac death prevention therapy. Major adverse arrhythmic cardiac events (MAACEs) were the primary endpoint. During a median follow-up of 959 days, MAACE occurred in 128 (9.2%) patients. In the multivariate analyses, male gender [hazard ratio (HR): 1.605 (95% confidence interval, CI: 1.051–2.451); P = 0.028], LVEF per point % [HR: 0.977 (95% CI: 0.961–0.993); P = 0.005] and presence and location of midwall LGE [weighted HR: 1.066 (95% CI: 1.045–1.086), P < 0.001] were independent predictors of MAACE. A multi-parametric CMR-weighted predictive-derived score (DERIVATE Risk Score 2.0) provided a higher additional prognostic value vs. transthoracic echocardiography–LVEF cut-off of 35% when compared with the previous published DERIVATE Risk Score 1.0 with a net reclassification improvement of 54.52% (95% CI: 36.52–72.52%; P < 0.001). These findings were confirmed in the validation cohort. Conclusion: The presence of midwall LGE, but also the location of scar, confers an added and independent MAACE risk to a large NICM population influencing the choice of treatment.
- Open Access
- 4 March 2025
- Published by Wiley in Magnetic Resonance in Medicine
- Vol. 93 (6) , 2386-2400
Free‐running 5D whole‐heart MRI for isotropic cardiac function measurements at 3T without contrast agents
Purpose: To optimize and characterize an interrupted 5D free‐running framework at 3 T for detailed cardiac function assessment without the use of breath holding or contrast agents. Methods: A free‐running 3D radial gradient echo sequence was periodically interrupted with a preparation and a recovery module to optimize native blood‐to‐myocardium contrast at 3 T. Lipid signal was suppressed using a numerically optimized water‐excitation RF pulse to reduce lipid streaking artifacts and to improve overall image quality. Optimal acquisition parameters were established for a 5‐min scan time using extended phase graph simulations. A compressed sensing‐based reconstruction incorporating cardiac and respiratory inter‐bin deformation fields was employed to generate 5D images of the whole heart. The sharpness and contrast between the left ventricular blood pool and myocardium, along with the functional measurements of the left ventricle from the 5D datasets, were compared to routine 2D cine imaging in 16 healthy volunteers and three patients referred for clinically indicated CMR. Results: The proposed method resulted in lower contrast vs. and sharpness vs. , but enabled similar left‐ventricle ejection fraction assessment , limits of , intraclass correlation with high reproducibility compared to 2D cine. Conclusion: The proposed contrast‐free, interrupted free‐running 5D imaging provides left ventricular functional assessments comparable to 2D cine at 3 T, while offering an improved patient experience through shorter scan times and free breathing.
- 4 March 2025
- Published by Wiley in Magnetic Resonance in Medicine
- Vol. 93 (6) , 2386-2400
Open AccessFree‐running 5D whole‐heart MRI for isotropic cardiac function measurements at 3T without contrast agents
Purpose: To optimize and characterize an interrupted 5D free‐running framework at 3 T for detailed cardiac function assessment without the use of breath holding or contrast agents. Methods: A free‐running 3D radial gradient echo sequence was periodically interrupted with a preparation and a recovery module to optimize native blood‐to‐myocardium contrast at 3 T. Lipid signal was suppressed using a numerically optimized water‐excitation RF pulse to reduce lipid streaking artifacts and to improve overall image quality. Optimal acquisition parameters were established for a 5‐min scan time using extended phase graph simulations. A compressed sensing‐based reconstruction incorporating cardiac and respiratory inter‐bin deformation fields was employed to generate 5D images of the whole heart. The sharpness and contrast between the left ventricular blood pool and myocardium, along with the functional measurements of the left ventricle from the 5D datasets, were compared to routine 2D cine imaging in 16 healthy volunteers and three patients referred for clinically indicated CMR. Results: The proposed method resulted in lower contrast vs. and sharpness vs. , but enabled similar left‐ventricle ejection fraction assessment , limits of , intraclass correlation with high reproducibility compared to 2D cine. Conclusion: The proposed contrast‐free, interrupted free‐running 5D imaging provides left ventricular functional assessments comparable to 2D cine at 3 T, while offering an improved patient experience through shorter scan times and free breathing.